EyePoint Pharmaceuticals (EYPT) EPS (Basic): 2010-2018
Historic EPS (Basic) for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Sep 2018 value amounting to -$0.44.
- EyePoint Pharmaceuticals' EPS (Basic) fell 193.33% to -$0.44 in Q3 2018 from the same period last year, while for Sep 2018 it was -$1.34, marking a year-over-year decrease of 179.40%. This contributed to the annual value of -$1.15 for FY2018, which is 121.15% down from last year.
- EyePoint Pharmaceuticals' EPS (Basic) amounted to -$0.44 in Q3 2018, which was up 29.03% from -$0.62 recorded in Q2 2018.
- Over the past 5 years, EyePoint Pharmaceuticals' EPS (Basic) peaked at $0.70 during Q3 2014, and registered a low of -$0.62 during Q2 2018.
- For the 3-year period, EyePoint Pharmaceuticals' EPS (Basic) averaged around -$0.22, with its median value being -$0.15 (2018).
- In the last 5 years, EyePoint Pharmaceuticals' EPS (Basic) skyrocketed by 600.00% in 2014 and then crashed by 563.14% in 2017.
- Quarterly analysis of 5 years shows EyePoint Pharmaceuticals' EPS (Basic) stood at -$0.14 in 2014, then declined by 28.57% to -$0.18 in 2015, then skyrocketed by 89.11% to -$0.02 in 2016, then slumped by 563.14% to -$0.13 in 2017, then crashed by 193.33% to -$0.44 in 2018.
- Its EPS (Basic) was -$0.44 in Q3 2018, compared to -$0.62 in Q2 2018 and -$0.15 in Q1 2018.